Journal of Endocrinological Investigation

, Volume 20, Issue 2, pp 90–107 | Cite as

The clinical evaluation of silent adrenal masses

  • B. Ambrosi
  • E. Passini
  • T. Re
  • L. Barbetta
Review Article


Incidentaloma Cushing’s syndrome adrenal tumor hypercortisolism adrenal adenoma congenital adrenal hyperplasia ACTH 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lewinsky B.S., Grigor K.M., Symington T., Neville A.M. The clinical and pathologic feature of “non-hormonal” adrenocortical tumors. Report of twenty new cases and review of the literature. Cancer 33: 778, 1974.PubMedGoogle Scholar
  2. 2.
    Copeland P.M. The incidentally discovered adrenal mass. Ann. Intern. Med. 95: 940, 1983.Google Scholar
  3. 3.
    Ross N.S., Aron D.C. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N. Engl. J. Med. 323: 1401, 1990.PubMedGoogle Scholar
  4. 4.
    Gross M.D., Shapiro B. Clinically silent adrenal masses. J. Clin. Endocrinol. Metab. 77: 885, 1993.PubMedGoogle Scholar
  5. 5.
    Belldegrun A., Hussain S., Seltzer S.E., Loughlin K.R., Gittes R.F., Richie J.P. Incidentally discovered mass of the adrenal gland. Surg. Gynecol. Obstet. 163: 203, 1986.PubMedGoogle Scholar
  6. 6.
    Herrera M.F., Grant C.S., Van Heerden J.A., Sheedy P.F., Ilstrup D.M. Incidentally discovered adrenal tumors: an institutional perspective. Surgery 110: 1014, 1991.PubMedGoogle Scholar
  7. 7.
    Kloos R.T., Gross M.D., Francis I.R., Korobkin M., Shapiro B. Incidentally discovered adrenal masses. Endocr. Rev. 16: 460, 1995.PubMedGoogle Scholar
  8. 8.
    Devenyi I. Possibility of normokalaemic primary aldosteronism as reflected in the frequency of adrenal cortical adenomas. J. Clin. Pathol. 20: 49, 1967.PubMedCentralPubMedGoogle Scholar
  9. 9.
    Russell R.P., Masi A.T., Richter E.D. Adrenal cortical adenomas and hypertension. A clinical pathologic analysis of 690 cases with matched controls and a review of the literature. Medicine (Baltimore) 51: 211, 1972.Google Scholar
  10. 10.
    Angeli A., Terzolo M., Osella G., Alì A. Adrenal incidentaloma (I): an overview of clinical and epidemiological data from the National Italian Study Group. 39èmes Journ. Intern. H.-P. Klotz Endocrin. Clin. Paris, 30–31 may 1996, (abs), p. 49, 1996.Google Scholar
  11. 11.
    Hedeland H., Ostberg G., Hokfelt B. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med. Scand. 184: 211, 1968.PubMedGoogle Scholar
  12. 12.
    Kokko J.P., Brown T.C., Berman M.M. Adrenal adenoma and hypertension. Lancet 1: 468, 1967.PubMedGoogle Scholar
  13. 13.
    Dobbie J.W. Adrenocortical nodular hyperplasia: the aging adrenal. J. Pathol. 99: 1, 1969.PubMedGoogle Scholar
  14. 14.
    Granger P., Genest J. Autopsy study of adrenals in unselected normotensive and hypertensive patients. Can. Med. Assoc. J. 103: 34, 1970.PubMedCentralPubMedGoogle Scholar
  15. 15.
    Neville A.M. The nodular adrenal. Invest. Cell. Pathol. 1: 99, 1978.PubMedGoogle Scholar
  16. 16.
    Reznek H.R., Armstrong P. Imaging in endocrinology. The adrenal gland. Clin. Endocrinol. 40: 561, 1994.Google Scholar
  17. 17.
    Lee M.J., Hahn P.F., Papanicolau N., Egglin T.K., Saini S., Mueller P.R., Simeone J.F. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179: 415, 1991.PubMedGoogle Scholar
  18. 18.
    Reining J.W., Doppman J.L., Dwyer A.J., Johnson A.R., Knop R.H. Adrenal masses differentiated by MR. Radiology 150: 81, 1986.Google Scholar
  19. 19.
    Chezmar J.L., Robbins S.M., Nelson R.C., Steinberg H.V., Torres W.E., Bernardino M.E. Adrenal masses: characterization with T1 weighted MR imaging. Radiology 166: 357, 1988.PubMedGoogle Scholar
  20. 20.
    Mitchell D.G., Crovello M., Matteucci T., Petersen R.O., Miettinen M.M. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 185: 345, 1992.PubMedGoogle Scholar
  21. 21.
    Baker M.E., Blinder R., Spritzer C., Leight G.S., Herfkens R.J., Dunnick N.R. MR evaluation of adrenal masses at 1.5 T. Am. J. Roentgenol. 153: 307, 1989.Google Scholar
  22. 22.
    van Erkel A.R., van Gils A.P., Lequin M., Kruitwagen C., Bloem J.L., Falke T.H. CT and MR distinction of adenomas and nonadenomas of the adrenal gland. J. Comput. Assist. Tomogr. 18: 432, 1994.PubMedGoogle Scholar
  23. 23.
    Reining W.J., Stutley J.E., Leonhardt C.M., Spicer K.M., Magrolis M., Cadwell C.B. Differentiation of adrenal masses with MR imaging: comparison of techniques. Radiology 192: 41, 1994.Google Scholar
  24. 24.
    Gross M.D., Shapiro B., Francis I.R., Glazer G.M., Bree R.L., Arcomano M.A., Schteingart D.E., McLeod M.K., Sanfield J.A., Thompson N.W. Scintigraphic evaluation of clinically silent adrenal masses (see comments). J. Nucl. Med. 35: 1145, 1994.PubMedGoogle Scholar
  25. 25.
    Khafagi F.A., Gross M.D., Shapiro B., Glazer G.M., Francis I., Thompson N.W. Clinical significance of the large adrenal mass. Br. J. Surg. 78: 828, 1991.PubMedGoogle Scholar
  26. 26.
    Gross M.D., Shapiro B., Francis I.R., Bree R.L., Korobkin M., McLeod M.K., Thompson N.W., Sanfield J.A. Scintigraphy of incidentally discovered bilateral adrenal masses. Eur. J. Nucl. Med. 22: 315, 1995.PubMedGoogle Scholar
  27. 27.
    Bardet S., Rohmer V., Murat A., Guillemot C., Marechaud R., Chupin M., Lecomte P., Simon D., Delemer B., Schneebelli S., Beutter D., Jacquin V., Peltier P., Charbonnel B. and the West France Study Group on Incidentalomas (WFSGI). 131-I-6β-Iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clin. Endocrinol. (Oxf). 44: 587, 1996.Google Scholar
  28. 28.
    Lavoie H., Lacroix A. Partially autonomous Cortisol secretion by incidentally discovered adrenal adenomas. Trends Endocrinol. Metab. 6: 191, 1995.PubMedGoogle Scholar
  29. 29.
    Chatal T., Charbonnel B. Comparison of iodobenzylguanidine imaging with computed tomography in locating phaeochromocytoma. J. Clin. Endocrinol. Metab. 61: 769, 1985.PubMedGoogle Scholar
  30. 30.
    Gross M.D., Shapiro B.S. Scintigraphic studies in adrenal hypertension. Semin. Nucl. Med. 19: 122, 1989.PubMedGoogle Scholar
  31. 31.
    van Gils A.P., Falke T.H., van Erkel A.R., van de Velde C.J., Pauwels E.K. Non-invasive imaging of functioning paragangliomas (including phaeochromocytomas). Front. Eur. Radiol. 7: 1, 1990.Google Scholar
  32. 32.
    Mantero F., Masini A.M., Opocher G., Giovagnetti M., Amaldi G. Adrenal incidentaloma (2): an overview of hormonal data from the national italian study group. 39èmes Journ. Intern. H.-P. Klotz Endocrin. Clin. Paris, 30–31 May 1996, (abs), p. 51, 1996.Google Scholar
  33. 33.
    Aso Y., Homma Y. A survey on incidental adrenal tumors in Japan. J. Urol. 147: 1478, 1992.PubMedGoogle Scholar
  34. 34.
    Hoefnagel C.A. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur. J. Nucl. Med. 21: 561, 1994.PubMedGoogle Scholar
  35. 35.
    Maurea S., Lastoria S., Caraco C., Klain M., Varrella P., Acampa W., Muto P., Salvatore M. The role of radiolabeled somatostatin analogs in adrenal imaging. Nucl. Med. Biol. 23: 677, 1996.PubMedGoogle Scholar
  36. 36.
    Gross M.D., Falke T.H.M., Shapiro B., Sandler M.P. Adrenal glands. In: Sandler M.P., Patton J.A., Gross M.D., Shapiro B., Falke T.H.M. (Eds.), Endocrine Imagines. Appleton and Lange, Norwalk, Connecticut, 1992, p. 271.Google Scholar
  37. 37.
    Bernardino M.E., Walther M.M., Phillips V.M., Graham Jr S.D., Sewell C.W., Gedgausas-McCless K., Baumgartner B.R., Torres W.E., Erwin B.C. CT-guided adrenal biopsy: accuracy, safety, and indications. Am. J. Roentgenol. 144: 67, 1985.Google Scholar
  38. 38.
    Yankaskas B.C., Staab E.V., Cravem M.B., et al. Delayed complications from fine-needle biopsies of solid masses of the abdomen. Invest. Radiol. 21: 325, 1986.PubMedGoogle Scholar
  39. 39.
    Oelkers W. Diagnostic puzzle of the adrenal “incidentaloma”. Eur. J. Endocrinol. 132: 419, 1995.PubMedGoogle Scholar
  40. 40.
    Cook D.M., Loriaux D.L. The incidental adrenal mass. The Endocrinologist 6: 4, 1996.Google Scholar
  41. 41.
    Hensen J., Buhl M., Bähr V., Oelkers W. Endocrine activity of the “silent” adrenocortical adenoma is uncovered by response to corticotropin-releasing-hormone. Klin. Wochenschr. 68: 608, 1990.PubMedGoogle Scholar
  42. 42.
    Jockenhovel F., Kuck W., Hauffa B., Reinhardt W., Benker G., Lederbogen S., Olbricht Th., Reinwein D. Consecutive and surgical management of incidentally discovered adrenal tumors (incidentalomas). J. Endocrinol. Invest. 15: 331, 1992.PubMedGoogle Scholar
  43. 43.
    Flecchia D., Mazza E., Carlini M., Blatto A., Olivieri F., Serra G., Camanni F., Messina M. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clin. Endocrinol. (Oxf). 42: 129, 1995.Google Scholar
  44. 44.
    Reincke M., Nieke J., Krestin G.P., Saeger W., Allolio B., Winkelmann W. Preclinical Cushing’s syndrome in adrenal “Incidentalomas”: comparison with adrenal Cushing’s syndrome. J. Clin. Endocrinol. Metab. 75: 826, 1992.PubMedGoogle Scholar
  45. 45.
    Caplan R.H., Strutt P.J., Wickus G.G. Subclinical hormone secretion by incidentally discovered adrenal masses. Arch. Surg. 129: 291, 1994.PubMedGoogle Scholar
  46. 46.
    Fernandezreal J.M., Ricartengel W., Simo R. Pre-clinical Cushing’s syndrome: report of three cases and literature review. Horm. Res. 41: 5, 1994.Google Scholar
  47. 47.
    Ambrosi B., Peverelli S., Passini E., Re T., Ferrario R., Colombo P., Sartorio A., Faglia G. Abnormalities of endocrine function in patients with clinically “silent” adrenal mass. Eur. J. Endocrinol. 132: 422, 1995.PubMedGoogle Scholar
  48. 48.
    Bencsik Z., Izabolks I., Goth M., Voros A., Kaszas I., Gonczi J., Kovacs L., Dohan O., Szilagyi G. Incidentally detected adrenal tumours (incidentalomas): histological heterogeneity and differentiated therapeutic approach. J. Intern. Med. 237: 585, 1995.PubMedGoogle Scholar
  49. 49.
    Terzolo M., Osella G., Alì A., Borretta G., Magro G., Termine A., Paccotti P., Angeli A. Different patterns of steroid secretion in patients with adrenal incidentaloma. J. Clin. Endocrinol. Metab. 81: 740, 1996.PubMedGoogle Scholar
  50. 50.
    Osella G., Terzolo M., Borretta G., Magro G., Alì A., Piovesan A., Paccotti P., Angeli A. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J. Clin. Endocrinol. Metab. 79: 1532, 1994.PubMedGoogle Scholar
  51. 51.
    Del Monte P., Bernasconi D., Bertolazzi L., Meozzi M., Badaracco B., Torre R., Marugo M. Increased 17-alfa-hydroxyprogesterone response to ACTH in silent adrenal adenoma: cause of effect? Clin. Endocrinol. (Oxf). 42: 273, 1995.Google Scholar
  52. 52.
    Bencsik Z., Szabolks I., Kovaks Z., Ferencz A., Voros A., Kaszas I., Bor K., Gonczi J., Goth M., Kovacs L., Dohan O., Szilagyi G. Low dehydroepiandrosterone sulfate (DHEAS-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumours. J. Clin. Endocrinol. Metab. 81: 126, 1996.Google Scholar
  53. 53.
    Toth M., Racz K., Varga I., Szucs N., Szabò P., Futò L., Kiss R., Glaz E. Plasma dehydroepiandrosterone sulfate levels in patients with hyperfunctioning and non-hyperfunctioning adrenal tumours before and following adrenal surgery. The Endocrine Society, 10th Int. Congr. Endocrinol., San Francisco, USA, June 12–15, 1996, p. 3–618 (abs), 1996.Google Scholar
  54. 54.
    Seppel T., Schlaghecke R. Augmented 17 a-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumour (‘incidentalomas’). Clin. Endocrinol. (Oxf). 41: 455, 1994.Google Scholar
  55. 55.
    Ravichandran R., Lafferty F., Mcginniss M.J., Taylor H.C. Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life: report of two patients with 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 81: 1776, 1996.PubMedGoogle Scholar
  56. 56.
    Jaresch S., Kornely E., Kley H.K., Schlaghecke R. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 74: 685, 1992.PubMedGoogle Scholar
  57. 57.
    Bauman A., Bauman C.G. Virilizing adrenocortical carcinoma. Development in a patient with salt-losing congenital adrenal hyperplasia. JAMA 248: 3140, 1982.PubMedGoogle Scholar
  58. 58.
    Jaursch-Hancke C., Allolio B., Metzler U., Bidlingmaier F., Winkelmann W. Adrenocortical carcinoma in patients with untreated congenital adrenal hyperplasia (CAH). Acta Endocrinol. (Copenh.) (Oxf). 177(Suppl.): 146, 1988.Google Scholar
  59. 59.
    Turton D.B., O’Brian J.T., Shakir M.M. Incidental adrenal nodules: association with exaggerated 17-hydroxyprogesterone response to adrenocorticotropic hormone. J. Endocrinol. Invest. 15: 789, 1992.PubMedGoogle Scholar
  60. 60.
    Aupetit-Faisant B., Blanchouin-Emeric N., Tenenbaum F., Battaglia C., Tabarin A., Amar J., Kuttenn F., Warnet A., Assayag B., Chamontin B., Touraine P.H., Lebrun P., Maunand B., Benoit A., Bletry O., Noel S., Lorcy Y., Allanic H., Legrand J.C. Plasma levels of aldosterone versus aldosterone precursors: a way to estimate the malignancy of asymptomatic and nonsecretory adrenal tumors: a French retrospective multicentric study. J. Clin. Endocrinol. Metab. 80: 2715, 1995.PubMedGoogle Scholar
  61. 61.
    Suzuki H, Shibata H., Maruyama T., Ishimura Y., Saruta T. Significance of steroidogenic enzymes in the pathogenesis of hyperfunctioning and non-hyperfunctioning adrenal tumor. Steroids 60: 42, 1995.PubMedGoogle Scholar
  62. 62.
    Siren J.E., Haapiainem R.K., Huikuri K.T., Sivula A. Incidentalomas of the adrenal gland: 36 operated patients and review of literature. World J. Surg. 17: 634, 1993.PubMedGoogle Scholar
  63. 63.
    Seppel T., Becker A., Feldkamp J., Santen R., Schlaghecke R. Risk factors for adrenocortical malignancy in patients with incidentally discovered adrenal tumours. J. Endocrinol. 144(Suppl.), P43 (abs.), 1995.Google Scholar
  64. 64.
    Hensen J., Walters P., Stark S., Buhl M., Vecsei P., Shao X.J., Rico A.J., Dorr H.G., Oelkers W. Hypertension and plasma potassium in patients with “non-functioning” adrenocortical adenoma. The Endocrine Society, 77th Annual Meeting, Washington, June 1995, P3–45 (abs.), 1995.Google Scholar
  65. 65.
    Furlani L., Deliera A., Alberiche M., Guerriero A., Muggeo M. Apparent 21-hydroxylase deficiency in incidentally discovered adrenal mass. J. Endocrinol. Invest. 19(Suppl. 5): 178 (abs.), 1996.Google Scholar
  66. 66.
    Racz K., Pinet F., Marton T., Szende B., Glaz E., Corvol P. Expression of steroidogenic enzyme messenger ribonucleic acids and corticosteroid production in aldosterone-producing and “nonfunctioning” adrenal adenomas. J. Clin. Endocrinol. Metab. 77: 677, 1993.PubMedGoogle Scholar
  67. 67.
    Murakami C., Ishibashi M., Kondo M. Adrenal myelolipoma associated with congenital adrenal 21-hydroxylase deficiency. Int. Med. 31: 803, 1992.Google Scholar
  68. 68.
    Bevan J.S., Rees A. Dexamethasone-suppressible adrenal tumour in untreated 21-hydroxylase deficiency. Clin. Endocrinol. (Oxf). 44: 733, 1996.Google Scholar
  69. 69.
    Nagasaka S., Kubota K., Motegi T., Hayashi E., Ohta M., Takahashi T., Iwasaki Y., Koike M., Nishikawa T., Sasano H., Murakami T. A case of silent 21-hydroxylase deficiency with persistent adrenal insufficiency after removal of an adrenal incidentaloma. Clin. Endocrinol. (Oxf). 44: 111, 1996.Google Scholar
  70. 70.
    Reincke M. Steroid secretions in patients with adrenal incidentalomas. J. Clin. Endocrinol. Metab. 81: 3811, 1996.PubMedGoogle Scholar
  71. 71.
    Passini E, Re T., Conti A., Sartorio A., Ambrosi B. Some aspects of preclinical Cushing’s syndrome of adrenal origin. J. Endocrinol. Invest. 19(Suppl. 5): 71 (abs.), 1996.Google Scholar
  72. 72.
    Tsagarakis S., Michaliou D., Vasilatou E., Nikolou H., Thalassinos N. Evidence for incomplete suppression of Cortisol on low-dose dexamethasone suppression test in patients with adrenal incidentalomas. Eur. J. Endocrinol. (Suppl. 2): 130 (abs.), 1994.Google Scholar
  73. 73.
    Charbonnel B., Chatal J.F., Ozanne P. Does the corticoadrenal adenoma with “pre-Cushing’s” syndrome exist? J. Nucl. Med. 22: 1059, 1981.PubMedGoogle Scholar
  74. 74.
    Beyer H.S., Doe R.P. Cortisol secretion by an incidentally discovered nonfunctional adrenal adenoma. J. Clin. Endocrinol. Metab. 62: 1317, 1986.PubMedGoogle Scholar
  75. 75.
    Bogner U., Eggens U., Hensen J., Oelkers W. Incidentally discovered ACTH-dependent adrenal adenoma presenting as “Pre-Cushing’s syndrome”. Acta Endocrinol. 111: 89, 1986.PubMedGoogle Scholar
  76. 76.
    Hensen J., Buhl M., Oelkers W. Diagnostisches und therapeutisches vorgehen bei patienten mit zufaellig entdeckten nebennierentumoren. In: Allolio B., Schulte H.M. (Eds.), Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen. Schattauer Verlag, Stuttgart, New York, 1990, p. 210.Google Scholar
  77. 77.
    McLeod M., Thompson N., Gross M., Bondenson A., Bondenson L. Sub-clinical Cushing’s syndrome in patients with adrenal gland incidentalomas. Pitfalls in diagnosis and management. Am. Surg. 56: 398, 1990.PubMedGoogle Scholar
  78. 78.
    Seppel T., Schlaghecke R. Subclinical hypercortisolism in incidentally detected adrenal adenoma. Deutch. Med. Wochen. 121: 503, 1996.Google Scholar
  79. 79.
    Kobayashi S., Seki T., Nonomura K., Gotoh T., Togashi M., Koyanagi T. Clinical experience of incidentally discovered adrenal tumor with particular reference to cortical function. J. Urol. 150: 8, 1993.PubMedGoogle Scholar
  80. 80.
    Hensen J., Buhl M., Oelkers W. The functional spectrum of adrenocortical adenomas. Med. Hypoth. 40: 217, 1993.Google Scholar
  81. 81.
    Bernini G., Sgrò M., Molea N., Franchi F. A documented clinical case of pre-Cushing’s syndrome. The Endocrinologist 5: 377, 1995.Google Scholar
  82. 82.
    Tsuboi Y., Ishikawa S., Fujisawa G., Okada K., Saito T. Possible pre-Cushing’s syndrome due to an adrenal adenoma incidentally discovered. Endoer. J. 42: 509, 1995.Google Scholar
  83. 83.
    Laudat M.H., Billaud L., Thomopoulos P., Vera O., Yllia A., Luton J.P. Evening urinary free corticoids: a screening test in Cushing’s syndrome and incidentally discovered adrenal tumours. Acta Endocrinol. (Copenh) 199: 459, 1988.Google Scholar
  84. 84.
    Morio H., Terano T., Yamamoto K., Tomizuka T., Oeda T., Saito Y., Tamura Y., Sasano H. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic Cortisol producing adrenal adenoma: comparison with adrenal Cushing’s syndrome and non-functional adrenal tumor. Endoer. J. 43: 387, 1996.Google Scholar
  85. 85.
    Ambrosi B., Sartorio A. Preclinical Cushing’s syndrome. Trends Endocrinol. Metab. 7: 113, 1996.PubMedGoogle Scholar
  86. 86.
    Loli P., Vignati F., Da Re N., Milella M., Gelli D. Incidentally discovered “nonhypersecretory adrenal adenomas”: a scintigraphic and hormonal evaluation. The Endocrine Society, 77th Annual Meeting, Washington, June 1995, P3–44 (abs), 1995.Google Scholar
  87. 87.
    Morioka M., Ohashi Y., Komatsu F., Sawada K., Ebara S., Ohashi T., Kondo K. Preclinical Cushing’s Syndrome: report of four cases and analysis of steroid contents in adenomas. Horm. Res. 46: 117, 1996.PubMedGoogle Scholar
  88. 88.
    Tobinaga J., Imai T., Funahashi H., Tanaka Y., Wada M., Morita T., Yamada F., Tsukamura K., Oiwa M., Kikumori T., Sasano H., Takagi H. Incidentally discovered adrenocortical adenomas are not fully nonfunctioning: immunohistochemical and dispersed adrenocortical cell study. Endoer. J. 43: 79, 1996.Google Scholar
  89. 89.
    Huiras C.M., Pehling G.B., Caplan R.H. Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas. JAMA 261: 894, 1989.PubMedGoogle Scholar
  90. 90.
    Virkkala A., Valimaki M., Pelkonen R., Huikuri K., Kahri A., Kivisaari L., Korhonen T., Salmi J., Seppala P. Endocrine abnormalities in patients with adrenal tumours incidentally discovered on computed tomography. Acta Endocrinol. (Copenh.) 121: 67, 1989.Google Scholar
  91. 91.
    Rosen H.N., Swartz S.L. Subtle glucocorticoid excess in patients with adrenal incidentaloma. Am. J. Med. 92: 213, 1992.PubMedGoogle Scholar
  92. 92.
    Sutton M.G., Sheps S.G., Lie J.T. Prevalence of clinically unsuspected phaeochromocytoma: a review of a 50-year autopsy series. Mayo Clin. Proc. 56: 354, 1981.PubMedGoogle Scholar
  93. 93.
    Krane N.K. Clinically unsuspected pheochromocytomas: experience at Henry Ford Hospital and a review of the literature. Ann. Intern. Med. 146: 54, 1986.Google Scholar
  94. 94.
    Yamakita N., Saitoh M., Mercado-Asis L.B. Asymptomatic adrenal tumor: 386 cases in Japan including seven of our own. Endocrinol. Jpn. 37: 671, 1990.PubMedGoogle Scholar
  95. 95.
    Mannelli M., Pupilli C., Lanzillotti R., Lanni L., Amorosi A., Credi G., Pratesi G. A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case. J. Endocrinol. Invest. 16: 817, 1993.PubMedGoogle Scholar
  96. 96.
    Sone H., Okuda Y., Nakamura Y., Ishikawa N., Yamaoka T., Kawakami Y., Odawara M., Matsushima T., Kaway K., Yamashita K. Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma — a false-positive case of adrenocortical adenoma and literature review. Horm. Res. 46: 138, 1996.PubMedGoogle Scholar
  97. 97.
    Reincke M., Peter M., Karl M. Does 21-hydroxylase deficiency play a role in the pathogenesis of non-functional adrenal adenomas? Exp. Clin. Endocrinol. (Suppl. 1) 102: 74, 1994.Google Scholar
  98. 98.
    Burgess J.R., Harle R.A., Tucker P., Parameswaran V., Davies P., Greenway T.M., Shepherd J.J. Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch. Surg. 131: 699, 1996.PubMedGoogle Scholar
  99. 99.
    Terzolo M., Boccuzzi A., Alì A., Osella G., Luceri S., Matrella C., Arcuno L., Borriero M., Rovero E., Angeli A. 24-hour profile of blood pressure in patients with adrenal incidentaloma. Comparison with adrenal Cushing’s Syndrome. The Endocrine Society, 10th Intern. Congr. Endocrinol., San Francisco, USA, June 12–15, 1996, P3–596 (abs), 1996.Google Scholar
  100. 100.
    Sartorio A., Conti A., Ferrario S., Passini E., Re T., Ambrosi B. Serum bone Gla protein (BGP) and carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in patients with Cushing’s syndrome before and after surgery. Postgrad. Med. J. 72: 419, 1996.PubMedCentralPubMedGoogle Scholar
  101. 101.
    Osella G., Terzolo M., Piovesan A., Alì A., Termine A., Reimondo G., Paccotti P., Angeli A. Markers of bone and collagen turnover in patients with adrenal incidentaloma. The Endocrine Society, 10th Intern. Congr. Endocrinol., San Francisco, USA, June 12–15, 1996, P3–623 (abs), 1996.Google Scholar
  102. 102.
    Sartorio A., Ambrosi B., Colombo P., Morabito F., Faglia G. Osteocalcin levels in Cushing’s disease before and after treatment. Horm. Metab. Res. 20: 70, 1988.PubMedGoogle Scholar
  103. 103.
    Piovesan A., Terzolo M., Reimondo G., Pia A., Codegone A., Osella G., Boccuzzi A., Paccotti P., Angeli A. Biochemical markers of bone and collagen turnover in acromegaly or Cushing’s syndrome. Horm. Metab. Res. 26: 234, 1994.PubMedGoogle Scholar
  104. 104.
    Mold J.W., Stein H.F. The cascade effect in the clinical care of patients. N. Engl. J. Med. 314: 512, 1986.PubMedGoogle Scholar
  105. 105.
    Abecassis M., McLoughlin M.J., Langer B., Kudlow J.E. Serendipitous adrenal masses: prevalence, significance and management. Am. J. Surg. 149: 783, 1985.PubMedGoogle Scholar
  106. 106.
    Glazer H.S., Weyman P.J., Sagel S.S., Levitt R.G., McClennan B.L. Nonfunctioning adrenal masses: incidental discovery on computed tomography. Am. J. Roentgenol. 139: 89, 1982.Google Scholar
  107. 107.
    Prinz R.A., Brooks M.H., Churchill R., Graner J.L., Lawrence A.M., Paloyan E., Sparagana M. Incidental asymptomatic adrenal masses detected by computed tomographic scanning. JAMA 248: 701, 1982.PubMedGoogle Scholar
  108. 108.
    Thompson N.W., Cheung P.S.Y. Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasm including incidentalomas. Surg. Clin. North Am. 67: 423, 1987.PubMedGoogle Scholar
  109. 109.
    Gross M.D., Shapiro B., Bouffard J.A. et al. Distinguishing benign from malignant euadrenal masses. Ann. Intern. Med. 109: 613, 1988.PubMedGoogle Scholar
  110. 110.
    Weisnagel S.J., Gagner M., Breton G., Pomp A., Pharand D., Lacroix A. Laparoscopic adrenalectomy. The Endocrinologist 6: 169, 1996.Google Scholar
  111. 111.
    Griffing G.T. Editorial: A-I-D-S: the new endocrine epidemic. J. Clin. Endocrinol. Metab. 79: 1530, 1994.PubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1997

Authors and Affiliations

  • B. Ambrosi
    • 1
  • E. Passini
    • 1
  • T. Re
    • 1
  • L. Barbetta
    • 1
  1. 1.Istituto di Scienze EndocrineUniversità di Milano, Ospedale Maggiore IRCCS - Pad. GranelliMilanoItaly

Personalised recommendations